The popularity of Viagra initially fueled a period of growth for major pharmaceutical companies, however recent changes present a uncertain scenario for shareholders. Off-patent competitors are eroding earnings, and https://sashavjqm620375.luwebs.com/42093604/viagra-and-pharma-a-risky-investment